Related Experiment Videos
Approaches in the management of acute respiratory failure in children
Margaret A Priestley1, Mark A Helfaer
1Department of Anesthesiology and Critical Care Medicine, The University of Pennsylvania School of Medicine, The Children's Hospital of Philadelphia, 19104, USA. Priestly@email.chop.edu
Insights
New strategies for pediatric acute respiratory distress syndrome (ARDS) focus on protective ventilation and adjunctive therapies to minimize lung injury and improve outcomes. Further clinical trials are needed to confirm efficacy.
Area of Science:
- Pediatric critical care medicine
- Respiratory physiology
- Neonatology
Background:
- Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are critical conditions in children, leading to substantial illness and death.
- Current management of pediatric ARDS lacks definitive preventive strategies.
Purpose of the Study:
- To review current strategies for minimizing ventilator-induced lung injury in pediatric ALI/ARDS.
- To highlight novel adjunctive therapies for improving clinical outcomes in pediatric ARDS.
Main Methods:
- Review of current literature on ventilatory strategies and adjunctive therapies for pediatric ALI/ARDS.
- Analysis of evidence for protective ventilation modes, lung recruitment maneuvers, and pharmacological interventions.
Main Results:
- Protective ventilation includes high-frequency oscillatory ventilation, airway pressure release ventilation, and partial liquid ventilation.
- Lung-protective strategies such as recruitment maneuvers, prone positioning, and kinetic therapy enhance oxygenation.
- Adjunctive therapies like inhaled nitric oxide, surfactant, specialized enteral formulas, and extracorporeal life support show potential but require further investigation.
Conclusions:
- A combination of protective ventilation and adjunctive therapies is anticipated to optimize treatment and outcomes for pediatric ARDS.
- Large, controlled clinical trials are essential to validate the effectiveness of these combined therapeutic approaches in pediatric populations.
Purpose Of Review:
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are conditions that are associated with significant morbidity and mortality in children. There have been no advances in preventing ARDS, but this review highlights strategies directed at minimizing ventilator-induced lung injury and other new adjunctive therapies in the care of these patients.
Recent Findings:
High-frequency oscillatory ventilation, airway pressure release ventilation, and partial liquid ventilation are potential protective ventilatory modes for children with ALI or ARDS. Recruitment maneuvers, prone positioning, and kinetic therapy are all reported to improve oxygenation by opening the lung while positive end-expiratory pressure maintains functional residual capacity. Inhaled nitric oxide and surfactant are used to reduce inspired oxygen concentration and facilitate gas exchange, but their efficacy in ARDS continues to be investigated. Also, early investigations suggest that a specialized enteral formula can be a useful adjunctive therapy by reducing lung inflammation and improving oxygenation. When mechanical ventilation and adjunctive therapies fail, extracorporeal life support continues to be used as a rescue therapy.
Summary:
It is likely that a combination of these therapies will maximize treatment and clinical outcomes in the future, but the only way that will be proven is through large controlled clinical trials in pediatric patients.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
Acute Respiratory Failure-IV
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: